Fulgent Genetics, Inc. Ratios

Ratios Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 26.76%47.07%63.22%54.35%49.90%56.63%78.70%78.29%59.28%36.12%37.82%
EBT Margin -77.46%-52.06%-24.45%-16.02%-21.71%2.09%69.18%68.65%30.60%-60.19%-18.33%
EBIT Margin -77.46%-52.34%5.02%-18.59%-23.75%-1.32%68.80%68.10%28.84%-67.61%-26.08%
EBITDA Margin -77.46%-52.34%5.02%-18.59%-23.75%-1.32%68.80%68.10%28.84%-67.61%-26.08%
Operating Margin -77.46%-52.34%5.02%-18.59%-23.75%-1.32%68.80%68.10%28.84%-67.61%-26.08%
Net Margin -257.67%-34.76%-74.78%-13.40%-21.88%3.26%51.56%51.12%23.17%-58.03%-15.07%
FCF Margin -401.25%-0.77%3.55%-8.35%-14.04%13.33%25.02%51.86%37.93%1.66%-6.79%
Efficiency
Assets Average 31.94M57.61M55.54M71.33M394.61M989.59M1,332.39M1,310.69M1,227.65M
Equity Average 56.39M54.33M52.66M66.96M326.08M867.63M1,217.88M1,202.99M1,134.66M
Invested Capital 58.31M54.48M54.18M51.15M82.78M584.41M1,185.69M1,284.87M1,158.80M1,160.84M
Asset Utilization Ratio 0.570.330.380.461.071.000.460.220.23
Leverage & Solvency
Interest Coverage Ratio 176.24-400.67434.81
Debt to Equity 0.030.020.010.020.03
Debt Ratio 0.020.020.010.020.02
Equity Ratio 10.000.940.950.950.930.810.910.920.920.93
Times Interest Earned 176.24-400.67434.81
Dividends & Payouts
FCF Payout Ratio 7.09
Valuation
Enterprise Value -0.49M176.22M51.58M26.25M213.09M965.29M2,557.38M353.62M429.72M302.76M
Market Capitalization 197.09M78.06M57.28M241.36M1,264.65M3,000.75M876.67M856.69M564.94M
Return Ratios
Return on Sales -2.58%-0.35%0.00%-0.11%-0.22%0.02%0.52%0.50%0.22%-0.57%-0.15%
Return on Capital Employed 0.03%-0.06%-0.10%-0.01%1.10%0.76%0.14%-0.16%-0.06%
Return on Invested Capital -0.04%-0.01%0.65%0.56%0.11%-0.15%-0.05%
Return on Assets 0.00%-0.03%-0.08%0.01%0.55%0.50%0.10%-0.12%-0.04%
Return on Equity 0.00%-0.04%-0.09%0.01%0.67%0.57%0.11%-0.14%-0.04%